Paeoniflorin, the Main Active Ingredient of Shuyu Capsule, Inhibits Ca_v1.2 and Regulates Calmodulin/Calmodulin-Dependent Protein Kinase II Signalling

Figure 2

Western blot and analysis of hippocampus tissue samples from the control/normal group, model group, Shuyu capsule group, bupleurum group, and paeony group. (a) CACNA1C protein level analysis (). (b) Analysis of calmodulin (CaM) protein level (, ). (c) Analysis of phosphorylated calmodulin-dependent protein kinase II (p-CaMKII) level (, and ). (d) Analysis of brain-derived neurotrophic factor (BDNF) protein expression (, ).

(a)

(b)

(c)

(d)